AzTrials
AzTrials

Intubation, IntratrachealPhase 4NCT00910156

Indirect Laryngoscopy for Nasal Intubation

A Phase 4 study testing Airtraq laryngoscope, Glidescope laryngoscope and Macintosh laryngoscope in people with Intubation, Intratracheal, run by General Hospital Linz at 1 site in Austria.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Comparison of ease and convenience of nasotracheal intubation with the use of the two indirect laryngoscopes, Airtraq or Glidescope, versus the traditionally used Macintosh laryngoscope. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Intubation, Intratracheal
What is being tested?
Airtraq laryngoscope, Glidescope laryngoscope and Macintosh laryngoscope
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
Not given
Where
1 siteAustria
Study dates
Start not givento not given
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • Adult, Older adult

Who may be able to join

  • nasotracheal intubation

Who cannot join

  • anticipated difficult airway
  • risk factors for gastric aspiration
  • history of bleeding
  • relevant allergy

Trial locations and contacts

1 site in 1 country.

Austria1 site
  • General Hospital Linz

    Linz, 4020

Other trials in Austria

About this study

Official title: Indirect Versus Direct Laryngoscopy for Routine Nasotracheal Intubation: a Pilot Study

Comparison of ease and convenience of nasotracheal intubation with the use of the two indirect laryngoscopes, Airtraq or Glidescope, versus the traditionally used Macintosh laryngoscope.

Being tested
Airtraq laryngoscope, Glidescope laryngoscope, Macintosh laryngoscope

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Airtraq laryngoscopeDevice

    Airtraq intubation

  • Glidescope laryngoscopeDevice

    glidescope intubation

  • Macintosh laryngoscopeDevice

    Macintosh intubation

Study groups in NCT00910156
Study groupRoleWhat they receive
AirtraqActive comparatorNot described
Receives: Device: Airtraq laryngoscope
GlidescopeActive comparatorNot described
Receives: Device: Glidescope laryngoscope
MacintoshActive comparatorNot described
Receives: Device: Macintosh laryngoscope

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Intubation Difficulty Scale (IDS)

Secondary outcomes (1)
  1. Posture of the intubator

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 May 2009 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
IDs, dates and publications
ClinicalTrials.gov ID
NCT00910156
Sponsor's protocol ID
P01
Status last verified
May 2009
First submitted
28 May 2009
Last updated
29 May 2009
Results posted
No

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Airtraq laryngoscope, Glidescope laryngoscope and Macintosh laryngoscope in people with Intubation, Intratracheal, run by General Hospital Linz at 1 site in Austria.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 May 2009. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Austria. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Intubation Difficulty Scale (IDS). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 May 2009.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in